title: Estrogenic modulation of uropathogenic Escherichia coli infection pathogenesis in a murine menopause model.
abstract: Recurrent urinary tract infections (UTIs), primarily caused by uropathogenic Escherichia coli (UPEC), annually affect over 13 million patients in the United States. Menopausal women are disproportionally susceptible, suggesting estrogen deficiency is a significant risk factor for chronic and recurrent UTI. How estrogen status governs susceptibility to UTIs remains unknown, and whether hormone therapy protects against UTIs remains controversial. Here, we used a mouse model of surgical menopause by ovariectomy and demonstrate a protective role for estrogen in UTI pathogenesis. We found that ovariectomized mice had significantly higher bacteriuria, a more robust inflammatory response, and increased production of the proinflammatory cytokine interleukin-6 (IL-6) upon UPEC infection compared to sham-operated controls. We further show that response of the urothelial stem cell niche to infection, normally activated to restore homeostasis after infection, was aberrant in ovariectomized mice with defective superficial urothelial cell differentiation. Finally, UPEC-infected ovariectomized mice showed a significant increase in quiescent intracellular bacterial reservoirs, which reside in the urothelium and can seed recurrent infections. Importantly, this and other ovariectomy-induced outcomes of UTI were reversible upon estrogen supplementation. Together, our findings establish ovariectomized mice as a model for UTIs in menopausal women and pinpoint specific events during course of infection that are most susceptible to estrogen deficiency. These findings have profound implications for the understanding of the role of estrogen and estrogen therapy in bladder health and pathogen defense mechanisms and open the door for prophylaxis for menopausal women with recurrent UTIs.
authors.affiliation: Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, Missouri, USA.
authors.forename: Caihong
authors.initials: C
authors.lastname: Wang
authors.forename: Jane W
authors.initials: JW
authors.lastname: Symington
authors.forename: Emily
authors.initials: E
authors.lastname: Ma
authors.forename: Bin
authors.initials: B
authors.lastname: Cao
authors.forename: Indira U
authors.initials: IU
authors.lastname: Mysorekar
mesh_terms: D000818:Animals; D001437:Bacteriuria; D003692:Delayed-Action Preparations; D004343:Drug Implants; D004927:Escherichia coli Infections / Q000378:metabolism / Q000382:microbiology / Q000473:pathology* / Q000652:urine; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology; D004967:Estrogens / Q000378:metabolism*; D005260:Female; D007249:Inflammation / Q000378:metabolism; D015850:Interleukin-6 / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D010052:Ovariectomy; D014481:United States; D014552:Urinary Tract Infections / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D056689:Uropathogenic Escherichia coli / Q000502:physiology*
chemical_list: D003692:Delayed-Action Preparations; D004343:Drug Implants; D004967:Estrogens; D015850:Interleukin-6; D004958:Estradiol